These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3024521)

  • 41. The role of cyclooxygenase and lipoxygenase pathways in the adhesive interaction between bovine polymorphonuclear leukocytes and bovine endothelial cells.
    Dunn CJ; Fleming WE; McGuire JC; Ohlmann GM; Gray GD
    Prostaglandins Leukot Med; 1986 Mar; 21(3):221-30. PubMed ID: 3010330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Wetterholm A; Macchia L; Haeggström JZ
    Arch Biochem Biophys; 1994 Jun; 311(2):263-71. PubMed ID: 8203889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A formyl peptide contracts guinea pig lung: role of arachidonic acid metabolites.
    Shore SA; Stimler-Gerard NP; Smith E; Drazen JM
    J Appl Physiol (1985); 1987 Dec; 63(6):2450-9. PubMed ID: 2893781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deficient induction of leukotriene synthesis in human neutrophils by lipoxygenase-deficient platelets.
    Kanaji K; Okuma M; Uchino H
    Blood; 1986 Apr; 67(4):903-8. PubMed ID: 3006834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
    Cohan V; McKenzie-White J; Triggiani M; Massey W; Kagey-Sobotka A; Lichtenstein LM
    Biochem Pharmacol; 1989 Dec; 38(24):4455-9. PubMed ID: 2481451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contrasting influence of two lipoxygenase inhibitors on hypoxic pulmonary vasoconstriction in anesthetized pigs.
    McCormack DG; Paterson NA
    Am Rev Respir Dis; 1989 Jan; 139(1):100-5. PubMed ID: 2463778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
    Tanaka K; Abe M; Shigematsu N
    Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.
    Moilanen E; Alanko J; Juhakoski A; Vapaatalo H
    Agents Actions; 1989 Aug; 28(1-2):83-8. PubMed ID: 2551152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
    Boctor AM; Burke C; Hovinga ME
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.
    Robak J; Duniec Z
    Biochem Pharmacol; 1982 Jun; 31(11):1955-9. PubMed ID: 6810898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complex effects of in vitro hyperoxia on alveolar macrophage arachidonic acid metabolism.
    Sporn PH; Murphy TM; Peters-Golden M
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):81-90. PubMed ID: 2155014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).
    Surette ME; Krump E; Picard S; Borgeat P
    Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of arachidonic acid 5-lipoxygenase of human polymorphonuclear leukocytes by esculetin.
    Panossian AG
    Biomed Biochim Acta; 1984; 43(12):1351-5. PubMed ID: 6100067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome P450 dependent arachidonic acid metabolism in hemopoietic cells.
    Lutton JD; Schwartzman ML; Abraham NG
    Adv Exp Med Biol; 1989; 271():115-21. PubMed ID: 2518598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C.
    Higgs GA; Mugridge KG; Moncada S; Vane JR
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2890-2. PubMed ID: 6326150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and structure elucidation of leukotrienes.
    Marfat A; Corey EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():155-228. PubMed ID: 2992244
    [No Abstract]   [Full Text] [Related]  

  • 57. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
    Takayama H; Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
    Prostaglandins Leukot Med; 1983 Nov; 12(3):261-72. PubMed ID: 6318227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrogen peroxide inhibits alveolar macrophage 5-lipoxygenase metabolism in association with depletion of ATP.
    Sporn PH; Peters-Golden M
    J Biol Chem; 1988 Oct; 263(29):14776-83. PubMed ID: 2844785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
    Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: comparison with indomethacin and ETYA.
    Van Wauwe J; Goossens J
    Prostaglandins; 1983 Nov; 26(5):725-30. PubMed ID: 6422509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.